VSLI

not specified · Acrotech Biopharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VSLI, covering 2020-01-03 to 2020-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL [Phase 1, Phase 2]